Toward a new landscape for the mechanism of immunosuppression in hepatocellular carcinoma

Hepatol Int. 2021 Apr;15(2):287-289. doi: 10.1007/s12072-021-10161-2. Epub 2021 Mar 13.

Chien-Wei Su^{1

2

3

4}, Han-Chieh Lin^{5

6}

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec. 2, Shih-Pai Road, Taipei, 11217, Taiwan.
² Hospitalist Ward, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
³ Department of Medicine, School of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁴ Biomedical Science and Engineering Center, National Tsing Hua University, Hsinchu, Taiwan.
⁵ Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec. 2, Shih-Pai Road, Taipei, 11217, Taiwan. hclin@vghtpe.gov.tw.
⁶ Department of Medicine, School of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. hclin@vghtpe.gov.tw.

No abstract available

Keywords: Biomarkers; Hepatocellular carcinoma; Systemic therapy.

MeSH terms